We identified ACTR3, ARPC2, and ARPC5 as independent prognostic biomarkers affecting the survival of HCC, and GSEA analysis was conducted to explore the potential biological mechanism by which Arp2/3 subunits lead to poor survival. This evidence concerns the gene ACTR2 and hepatocellular carcinoma.